VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $269,507 | -7.9% | 16,626 | -5.4% | 0.00% | – |
Q1 2023 | $292,607 | +103.6% | 17,574 | +14.9% | 0.00% | – |
Q4 2022 | $143,735 | +219.4% | 15,291 | -6.7% | 0.00% | – |
Q3 2022 | $45,000 | -15.1% | 16,382 | -10.8% | 0.00% | – |
Q2 2022 | $53,000 | -72.8% | 18,356 | -40.9% | 0.00% | – |
Q3 2021 | $195,000 | +9.6% | 31,050 | +4.8% | 0.00% | – |
Q2 2021 | $178,000 | -2.7% | 29,633 | +2.3% | 0.00% | – |
Q1 2021 | $183,000 | +60.5% | 28,956 | +42.7% | 0.00% | – |
Q4 2020 | $114,000 | -30.9% | 20,297 | -28.4% | 0.00% | – |
Q3 2020 | $165,000 | -27.9% | 28,330 | -11.0% | 0.00% | – |
Q2 2020 | $229,000 | +23.1% | 31,822 | -19.7% | 0.00% | – |
Q1 2020 | $186,000 | -42.2% | 39,648 | -1.1% | 0.00% | – |
Q4 2019 | $322,000 | +22.4% | 40,094 | +4.9% | 0.00% | – |
Q3 2019 | $263,000 | -18.1% | 38,209 | -1.2% | 0.00% | – |
Q2 2019 | $321,000 | -13.2% | 38,687 | +3.8% | 0.00% | -100.0% |
Q1 2019 | $370,000 | +118.9% | 37,260 | +68.3% | 0.00% | – |
Q4 2018 | $169,000 | – | 22,135 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |